Intradermal LPS and Antibiotics

NCT03779360 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Inflammation; Skin

Interventions

DRUG: Erythromycin 4% topical gel formulation:
DRUG: Clindamycin 1% lotion formulation:
DRUG: Prednisolone tablet (0.5mg/kg; parallel comparison):
DRUG: Clobetasol propionate 0.05% topical formulation (crossover comparison):
OTHER: Lipopolysaccharide

Sponsor

Centre for Human Drug Research, Netherlands

Collaborators

[object Object]